background
sinc
dec
caus
fifti
thousand
patient
two
thousand
death
wuhan
china
report
characterist
patient
epidem
ongo
outbreak
wuhan
method
data
patient
clinic
outcom
design
hospit
wuhan
retrospect
collect
electron
medic
record
characterist
compar
patient
die
recov
patient
differ
diseas
sever
result
feb
patient
enrol
die
recov
nonsurvivor
tend
male
old
age
chronic
diseas
durat
ill
onset
admiss
day
patient
sever
critic
ill
day
onset
admiss
compar
ordinari
ill
lymphopenia
anemia
hypoproteinemia
abnorm
serum
sodium
present
case
respect
patient
die
severecrit
ill
show
increas
white
blood
cell
neutrophil
count
serum
total
bilirubin
creatinin
hypersensit
troponin
ddimer
procalcitonin
creactiv
protein
decreas
red
blood
cell
lymphocyt
platelet
count
serum
albumin
admiss
compar
recov
ordinari
ill
complic
acut
organ
injuri
secondari
infect
common
patient
especi
nonsurvivor
conclus
multipl
homeostasi
disturb
common
patient
sever
critic
ill
admiss
earli
support
provid
especi
old
men
chronic
diseas
vital
control
diseas
progress
reduc
mortal
epidem
ongo
outbreak
late
decemb
cluster
case
pneumonia
unknown
etiolog
report
local
health
facil
wuhan
china
novel
coronaviru
identifi
pathogen
acut
respiratori
ill
name
world
health
organ
similar
gene
sequenc
sever
acut
respiratori
syndrom
coronaviru
sarscov
diseas
caus
latterli
design
epidem
rapidli
spread
wuhan
area
jan
declar
epidem
public
health
emerg
intern
concern
newli
discov
viru
brought
much
seriou
global
health
threat
two
former
major
pandem
member
coronaviru
famili
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
mar
total
case
confirm
global
includ
china
case
countriesterritoriesarea
patient
die
china
abroad
data
earli
epidem
reveal
common
symptom
infect
includ
fever
fatigu
dri
cough
short
breath
older
male
comorbid
suscept
infect
progress
sever
even
fatal
respiratori
diseas
humantohuman
transmiss
confirm
mainli
respiratori
droplet
close
contact
manag
patient
infect
mainli
symptomat
treatment
life
support
sever
critic
ill
patient
antivir
treatment
list
protocol
issu
chines
nation
health
commiss
nhc
howev
antivir
agent
yet
confirm
effect
current
infect
patient
caus
death
wuhan
china
howev
littl
inform
focus
final
outcom
diseas
sever
admiss
obtain
associ
clinic
characterist
ongo
outbreak
pneumonia
retrospect
studi
aim
describ
compar
clinic
featur
patient
relat
final
outcom
diseas
sever
admiss
ongo
outbreak
wuhan
china
retrospect
singlecent
studi
patient
admit
eastern
campu
renmin
hospit
wuhan
univers
recruit
jan
feb
renmin
hospit
wuhan
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
nurs
record
also
review
necessari
patient
demograph
inform
histori
smoke
drink
chronic
diseas
onset
symptom
collect
well
durat
ill
onset
hospit
admiss
diseas
sever
admiss
index
laboratori
test
admiss
evalu
includ
complet
blood
count
c
reactiv
protein
crp
blood
biochemistri
myocardi
enzym
coagul
function
find
chest
comput
tomograph
scan
ct
xray
film
admiss
review
list
diseas
sever
ordinari
sever
critic
determin
accord
guidanc
issu
nhc
treatment
measur
evalu
research
contain
highflow
nasal
cannula
oxygen
therapi
hfnc
noninvas
mechan
ventil
nimv
invas
mechan
ventil
imv
blood
purif
treatment
applic
antivir
agent
antibacteri
agent
antifung
agent
corticosteroid
immunoglobulin
primari
endpoint
studi
patient
clinic
outcom
die
recov
secondari
endpoint
diseas
sever
admiss
criteria
recoveri
follow
temperatur
return
normal
day
respiratori
symptom
improv
significantli
neg
result
two
consecut
rna
detect
respiratori
sampl
sampl
interv
least
day
categor
variabl
present
number
continu
variabl
describ
mean
standard
deviat
sd
normal
distribut
data
median
interquartil
rang
iqr
abnorm
distribut
data
independ
test
use
compar
continu
variabl
normal
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
feb
patient
confirm
admit
eastern
campu
renmin
hospit
wuhan
univers
five
hundr
seventi
four
patient
still
hospit
time
four
hundr
eleven
patient
clinic
outcom
among
die
admiss
day
consequ
case
final
enrol
studi
die
recov
figur
median
age
year
male
nonsurvivor
significantli
older
age
survivor
median
year
vs
year
p
mortal
obvious
higher
male
femal
twenti
nine
patient
histori
smoke
histori
drink
histori
smoke
drink
associ
clinic
outcom
one
hundr
seventi
five
patient
chronic
diseas
nonsurvivor
higher
incid
chronic
diseas
compar
survivor
vs
p
one
hundr
thirteen
patient
hypertens
thirti
nine
patient
cerebrovascular
diseas
fifti
seven
patient
diabet
besid
coronari
heart
diseas
chronic
pulmonari
diseas
cirrhosi
anemia
chronic
kidney
diseas
appear
patient
respect
fever
account
main
symptom
onset
main
onset
symptom
cough
fatigu
median
durat
onset
symptom
hospit
admiss
day
admiss
patient
abnorm
lung
imag
manifest
chest
comput
tomographi
ct
scan
xray
film
typic
abnorm
chest
ct
imag
bilater
ground
glass
opac
subsegment
consolid
bilater
involv
appear
patient
tabl
laboratori
find
patient
list
tabl
tabl
result
complet
blood
cell
count
test
show
anemia
lymphopenia
case
nonsurvivor
exhibit
significantli
higher
white
blood
cell
neutrophil
count
lower
red
blood
cell
lymphocyt
platelet
count
admiss
survivor
two
hundr
seventi
patient
serum
albumin
level
gl
admiss
increas
serum
total
bilirubin
creatinin
observ
patient
respect
nonsurvivor
much
larger
proport
elev
total
bilirubin
vs
p
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
creatinin
vs
p
survivor
rais
serum
level
hypersensit
troponin
complic
acut
organ
injuri
secondari
infect
common
patient
especi
nonsurvivor
incid
acut
respiratori
distress
syndrom
vs
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
acut
liver
injuri
vs
cardiac
injuri
vs
kidney
injuri
vs
secondari
infect
vs
patient
die
significantli
higher
recov
p
hfnc
use
case
nimv
imv
provid
case
respect
thirti
nine
patient
receiv
blood
purif
treatment
antibiot
antifung
agent
given
case
respect
antivir
agent
knowledg
report
present
largest
sampl
patient
clinic
outcom
result
confirm
find
chen
male
gender
older
age
chronic
diseas
contribut
death
caus
infect
patient
sever
critic
ill
admiss
present
delay
admiss
impli
effect
delay
admiss
diseas
deterior
ongo
outbreak
epidem
incur
sharpli
increas
patient
wuhan
china
could
nt
admit
hospit
time
frequent
visit
fever
clinic
inappropri
home
quarantin
delay
hospit
aggrav
diseas
progress
transmiss
viru
multipl
homeostasi
disturb
includ
lymphopenia
anemia
hypoproteinemia
abnorm
serum
sodium
observ
admiss
especi
patient
sever
critic
ill
mani
factor
might
contribut
disturb
eat
less
due
poor
appetit
food
augment
organ
consumpt
simultan
gastrointestin
problem
insuffici
nutrient
intak
augment
consumpt
might
deterior
tissu
metabol
damag
one
immun
viru
studi
show
multipl
organ
damag
ard
acut
kidney
injuri
acut
cardiac
injuri
acut
liver
injuri
common
complic
patient
previou
studi
show
angiotensinconvert
enzym
receptor
express
organ
includ
lung
heart
liver
kidney
bind
provid
direct
attack
organ
serum
crp
level
admiss
evid
elev
patient
especi
sever
critic
ill
indic
excess
inflammatori
stress
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
consist
elev
serum
proinflammatori
cytokin
observ
patient
meanwhil
serum
level
laboratori
index
total
bilirubin
creatinin
hypersensit
troponin
increas
patient
admiss
trend
obviou
patient
sever
critic
ill
indic
sign
organ
damag
though
patholog
mechan
yet
defin
direct
attack
organ
damag
caus
excess
inflammatori
respons
cytokin
storm
might
respons
pathogenesi
diseas
progress
secondari
infect
anoth
main
complic
studi
appear
mostli
nonsurvivor
indic
import
booster
diseas
progress
comprehens
treatment
provid
patient
studi
antivir
treatment
coronaviru
infect
proven
effect
howev
antivir
agent
appli
almost
patient
main
agent
use
includ
abidol
oseltamivir
ribavirin
ganciclovir
recombin
interferon
remdesivir
chloroquin
consid
two
promis
agent
infect
given
patient
random
doubleblind
placebocontrol
clinic
trial
howev
hardli
assess
efficaci
safeti
remdesivir
chloroquin
result
trial
releas
shortterm
day
applic
glucocorticoid
suggest
sever
patient
protocol
issu
nhc
studi
glucocorticoid
appli
case
patient
sever
critic
ill
howev
glucocorticoid
use
found
correl
increas
mortal
sar
patient
delay
viru
clearanc
context
glucocorticoid
routin
recommend
treatment
pneumonia
studi
secondari
infect
appear
mostli
patient
glucocorticoid
use
might
contribut
death
indic
higher
incid
patient
die
vs
p
glucocorticoid
use
cautious
patient
highflow
nasal
cannula
oxygen
therapi
hfnc
mechan
ventil
recommend
patient
ard
noninvas
posit
pressur
ventil
nippv
advantag
improv
oxygen
patient
moder
sever
hypox
respiratori
failur
oxygen
index
howev
reduc
rate
endotrach
intub
icu
mortal
patient
ard
invas
ventil
strategi
pulmonari
protect
strongli
recommend
studi
mani
patient
sever
ard
provid
imv
treatment
inadequ
applic
invas
ventil
studi
mainli
due
shortag
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
intens
care
unit
icu
resourc
mani
critic
ill
patient
accumul
epidem
ongo
outbreak
worri
aerosol
transmiss
viru
endotrach
intub
possibl
anoth
reason
medic
staff
limit
studi
first
current
criteria
recoveri
debat
sinc
posit
result
rna
detect
appear
discharg
patient
one
two
week
continu
quarantin
henc
discharg
patient
may
truli
recov
second
agent
given
patient
antibiot
antiviru
agent
antifung
might
exert
toxic
organ
confound
judgment
organ
damag
viru
excess
inflammatori
stress
besid
chronic
diseas
might
also
effect
laboratori
result
patient
admiss
especi
sever
critic
ill
third
inflammatori
mediat
commonli
use
predict
cytokin
storm
includ
due
detect
small
fraction
patient
studi
howev
serum
crp
level
detect
patient
studi
also
reflect
inflammatori
stress
sinc
dec
infect
fifti
thousand
patient
caus
two
thousand
death
wuhan
china
strengthen
support
central
local
govern
nation
medic
staff
epidem
preliminari
control
wuhan
china
current
mani
countri
itali
iran
korea
howev
show
ongo
outbreak
inevit
bring
shortag
medic
resourc
learn
characterist
patient
wuhan
china
ongo
outbreak
epidem
help
other
make
appropri
strategi
thu
reduc
mortal
global
conclus
find
studi
suggest
multipl
homeostasi
disturb
patient
sever
critic
ill
admiss
includ
lymphopenia
anemia
hypoproteinemia
abnorm
serum
sodium
elev
inflammatori
stress
acut
organ
injuri
common
nonsurvivor
might
caus
attack
excess
inflammatori
respons
earli
support
therapi
provid
control
diseas
progress
reduc
mortal
thank
patient
famili
involv
studi
fund
sourc
studi
receiv
fund
author
declar
compet
interest
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
xl
ly
bz
idea
design
studi
full
access
data
studi
take
respons
integr
data
accuraci
data
analysi
wz
hx
bw
wy
contribut
write
report
xl
contribut
critic
revis
report
bw
tg
contribut
statist
analysi
author
contribut
data
acquisit
analysi
interpret
review
approv
final
version
data
set
support
find
current
studi
avail
correspond
author
reason
request
age
day
onset
admiss
present
median
interquartil
rang
compar
mannwhitney
test
patient
die
recov
chisquar
test
conduct
compar
categor
variabl
two
group
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
tabl
